Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease

Digestive Diseases and Sciences

Volumn 45, Issue 6, 2000, Pages 1121-1129

  Korzenik, Joshua R ^a   Dieckgraefe, Brian K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; Immunodeficiency; Inflammatory bowel disease; Neutrophil

Indexed keywords

ARTICLE; CELL FUNCTION; CROHN DISEASE; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; INTESTINE FLORA; NEUTROPHIL; PATHOGENESIS; PERIODONTITIS; PRIORITY JOURNAL; T LYMPHOCYTE;

CROHN DISEASE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MODELS, IMMUNOLOGICAL; NEUTROPHILS;

EID: 0034125228     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005541700805     Document Type: Article

References (97)

1. 1. Elson C: The basis of current and future therapy for inflammatory bowel disease. Am J Med 100:656-662, 1996
2. 2. Sartor RB: Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92(12 suppl):5S-11S, 1997
3. 3. Lopez-Cubero S, Sullivan K, McDonald G: Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1 14:433-440, 1998
4. 4. Sustento-Reodica N, Ruiz P, Rogers A, Viciana AL, Conn HO, Tzakis AG: Recurrent Crohn's disease in transplanted bowel. Lancet 349(9053):688-691, 1997
5. 5. Werlin SL, Chusid MJ, Caya J, Oechler HW: Colitis in chronic granulomatous disease. Gastroenterology 82(2):328-331, 1982
6. 6. Lindahl JA, Williams FH, Newman SL: Small bowel obstruction in chronic granulomatous disease. J Pediat Gastroenterol Nutr 3(4):637-640, 1984
7. 7. Isaacs D, Wright VM, Shaw DG, Raafat F, Walker-Smith JA: Chronic granulomatous disease mimicking Crohn's disease. J Pediatr Gastroenterol Nutr 4(3):498-501, 1985
8. 8. Fisher JE, Khan AR, Heitlinger L, Allen JE, Afshani E: Chronic granulomatous disease of childhood with acute ulcerative colitis: A unique association. Pediat Pathol 7(1):91-96, 1987
9. 9. Ahlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U, Rabbani H, Palmblad J, Elinder G: Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 84(12):1386-1394, 1995
10. 10. Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A: Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediat 126(1):143-145, 1995
11. 11. Sloan JM, Cameron CH, Maxwell RJ, McCluskey DR, Collins JS: Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut 38(4):619-622, 1996
12. 12. Hoare S, Walsh JE, Eastham E, Abinun MA, Cant AJ: Abnormal technetium labelled white cell scan in the colitis of chronic granulomatous disease. Arch Dis Child 77(1):50-51, 1997
13. 13. Myrup B, Valerius NH, Mortensen PB: Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 42(1):127-130, 1998
14. 14. Roe TF, Thomas DW, Gilsanz V, Isaacs H, Jr., Atkinson JB: Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr 109(1):55-59, 1986
15. 15. Sanderson IR, Bisset WM, Milla PJ, Leonard JV: Chronic inflammatory bowel disease in glycogen storage disease type IB. J Inherit Metab Dis 14(5):771-776, 1991
16. 16. Couper R, Kapelushnik J, Griffiths AM: Neutrophil dysfunction in glycogen storage disease Ib: Association with Crohn's-like colitis. Gastroenterology 100(2):549-554, 1991
17. 17. Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V: Brief report: Treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 326(25): 1666-1669, 1992
18. 18. Wendel U, Schroten H, Burdach S, Wahn V: Glycogen storage disease type Ib: Infectious complications and measures for prevention. European J Pediatr 152(suppl 1):S49-S51, 1993
19. 19. Schulman H, Weizman Z, Barki Y, Maor E, Hertzanu Y: Inflammatory bowel disease in glycogen storage disease type I B. Pediatr Radiol 25(suppl 1):S160-S162, 1995
20. 20. Hoover EG, DuBois JJ, Samples TL, McCullough JS, Chenaille PJ, Montes RG: Treatment of chronic enteritis in glycogen storage disease type IB with granulocyte colony-stimulating factor. J Pediatr Gastroenterol Nutr 22(4):346-350, 1996
21. 21. Franceschini R, Gianetta E, Pastorino A, Dallegri F, Cataldi A, Corsini G, Barreca T: Crohn's-like colitis in glycogen storage disease Ib: A case report. Hepato-Gastroenterol 43(12): 1461-1464, 1996
22. 22. D'Agata ID, Paradis K, Chad Z, Bonny Y, Seidman E: Leukocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 39:605-608, 1996
23. 23. Ishii E, Matui T, Iida M, Inamitu T, Ueda K: Chediak-Higashi syndrome with intestinal complication. Report of a case. J Clin Gastroenterol 9(5):556-558, 1987
24. 24. Knudtzon J, Ledaal P, Middelthon-Moe M, Aarskog D: 45,X/ 47,XY,-13 mosaicism and Crohn's disease. Acta Paediatr Scand 77(6):922-924, 1988
25. 25. Knudtzon J, Svane S: Turner's syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature. Acta Med Scand 223(4):375-378, 1988
26. 26. Kohler JA, Grant DB: Crohn's disease in Turner's syndrome. Br Med J Clin Res Ed 282(6268):950, 1981
27. 27. Vannier JP, Arnaud-Battandier F, Ricour C, Schmitz J, Buriot D, Griscelli C, Rey J: Chronic neutropenia and Crohn's disease in childhood. Arch Fr Pediatr 39(6):367-370, 1982
28. 28. Fata F, Myers P, Addeo J, Grinberg M, Nawabi I, Cappell MS: Cyclic neutropenia in Crohn's ileocolitis: Efficacy of granulocyte colony-stimulating factor. J Clin Gastroenterol 24(4):253-256, 1997
29. 29. Lamport RD, Katz S, Eskreis D: Crohn's disease associated with cyclic neutropenia. Am J Gastroenterol 87(11):1638-1642, 1992
30. 30. Stevens C, Peppercorn MA, Grand RJ: Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol 13(3):328-330, 1991
31. 31. Harewood GC, Loftus EV, Teffen A, Tremaine WJ, Sandhorn WJ: Concurrent inflammatory bowel disease and melodysplastic syndromes. Inflammatory Bowel Diseases 5:98-103, 1999
32. 32. Harewood G, Loftus E, Sanborn W, Tremaine W: Concurrent inflammatory bowel disease and the leukemias. Gastroenterology 114:A992, 1998
33. 33. D'Agata I, Paradis K, Chad Z, Bonny Y, Seidman E: Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 39:605-608, 1996
34. 34. Baehner RL: Chronic granulomatous disease of childhood: Clinical, pathological, biochemical, molecular, and genetic aspects of the disease. Pediatr Pathol 10(1-2):143-153, 1990
35. 35. Lopez-Osuna M, Vega-Avila E, Salamanca F, Kretschmer RR: Defective polymorphonuclear chemotaxis in patients with Turner's syndrome (45,X). Clin Genet 34(3):165-171, 1988
36. 36. Vaughan D, Drumm B: Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease. N Engl J Med 340(3):239-240, 1999
37. 37. Segal AW, Loewi G: Neutrophil dysfunction in Crohn's disease. Lancet 2(7979):219-221, 1976
38. 38. O'Morain C, Segal AA, Walker D, Levi AJ: Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut 22(10):817-822, 1981
39. 39. Verspaget HW, Pena AS, Weterman IT, Lamers CB: Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 29(2):223-228, 1988
40. 40. Curran FT, Allan RN, Keighley MR: Superoxide production by Crolm's disease neutrophils. Gut 32(4):399-402, 1991
41. 41. Gionchetti P, Campieri M, Guarnieri C, Belluzzi A, Brignola C, Bertinelli E, Ferretti M, Miglioli M, Barbara L: Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission. Dig Dis Sci 39(3):550-554, 1994
42. 42. Curran FT, Youngs DJ, Allan RN, Keighley MR: Candidacidal activity of Crohn's disease neutrophils. Gut 32(1):55-60, 1991
43. 43. Wandall JH: Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis. Scand J Gastroenterol 20(9):1151-1156, 1985
44. 44. Okabe N, Ikura S, Uchida Y, Fujita K, Yao T: Immunological studies on Crohn's disease. VIII. Diminished phagocytic activity in peripheral blood monocytes. J Clin Lab Immunnl 32(1):29-31, 1990
45. 45. Elmgreen J: Complement and function of neutrophils in chronic inflammatory bowel disease. Dan Med Bull 33(5):222-228, 1986
46. 46. Clemens DL, Horwitz MA: Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med 181(1):257-270, 1995
47. 47. Dell'Angelica E, Shotelersuk V, Aguilar R, Gahl W, Bonifacino J: Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell 3:11-21, 1999
48. 48. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M, Decker T, Wynshaw-Boris A, Xanthopoulos KG: Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 94(24):13187-13192, 1997
49. 49. Yamanaka R, Kim GD, Radomska HS, Lekstrom-Himes J, Smith LT, Antonson P, Tenen DG, Xanthopoulos KG: CCAAT/enhancer binding protein epsilon is preferentially upregulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 94(12):6462-6467, 1997
50. 50. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S: Enhanced Th1 activity and development of chronic entercolitis in mice devoid of Slat3 in macrophages and neutrophils. Immunity 10:39-49, 1999
51. 51. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcer-ative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990-996, 1988
52. 52. Wilson M, Reddi K, Henderson B: Cytokine-inducing components of periodontopathogenic bacteria. J Periodont Res 31:393-407, 1996
53. 53. Hart TC, Shapira L, Van Dyke TE: Neutrophil defects as risk factors for periodontal diseases. J Periodontol 65(5 suppl):521-529, 1994
54. 54. Van Dyke T, Vaikuntam J: Neutrophil function and dysfunction in periodontal disease. Curr Opin Peridontol 2:19-27, 1994
55. 55. Van Dyke TE, Offenbacher S, Place D, Dowell VR, Jones J: Refractory periodontitis: Mixed infection with Bacteroides gingivalis and other unusual Bacteroides species. A case report. J Periodontol 59(3):184-189, 1988
56. 56. Van Dyke TE, Dowell VR Jr, Offenbacher S, Snyder W. Hersh T: Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun 53(3):671-677, 1986
57. 57. Wilton JM, Hurst TJ, Scott EE: Inhibition of polymorphonuclear leucocyte phagocytosis by Porphyromonas gingivalis culture products in patients with adult periodontitis. Arch Oral Biol 38(4):285-289, 1993
58. 58. Ohta H, Kokeguchi S, Fukui K, Kato K: Leukotoxic activity in Actinobacillus (Haemophilus) actinomycetemcomitans isolated from periodontal disease patients. Microbiol Immunol 31(4):313-325, 1987
59. 59. Scragg MA, Turton LR, Newman HN, Williams DM: Effects of Porphyromonas gingivalis culture products on the morphology of peripheral blood polymorphonuclear leucocytes from periodontitis patients and healthy subjects. J Clin Periodontol 22(8):585-590, 1995
60. 60. Janowitz HD, Croen EC, Sachar DB: The role of the fecal stream in Crohn's disease: An historical and analytic review. Inflamm Bowel Dis 4(1):29-39, 1998
61. 61. Harper PH, Lee EC, Kettlewell MG, Bennett MK, Jewell DP: Role of the faecal stream in the maintenance of Crohn's colitis. Gut 26(3):279-284, 1985
62. 62. Keighley MR, Arabi Y, Dimock F, Burdon DW, Allan RN, Alexander-Williams J: Influence of inflammatory bowel disease on intestinal microflora. Gut 19(12):1099-1104, 1978
63. 63. Giaffer MH, Holdsworth CD, Duerden BI: The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 35(4):238-243, 1991
64. 64. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J: Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 42(4):817-822, 1997
65. 65. Rotstein OD, Vittorini T, Kao J, McBurney MI, Nasmith PE, Grinstein S: A soluble Bacteroides by-product impairs phagocytic killing of Escherichia coli by neutrophils. Infect Immun 57(3):745-753, 1989
66. 66. Madsen KL, Taverini MM, Doyle JSG, RN. F: Lactobacillus SP prevents development of enterocolitis in interleukin-10 gene deficient mice. Gastroenterology 112:A1030, 1997
67. 67. Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, et al: The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolilis in rats. Gastroenterology 111:334-344, 1996
68. 68. Muscettola M, Massal L, Tanganelli C, Grasso G: Effects of lactobacilli on interferon production in young and aged mice. Ann NY Acad Sci 717:226-232, 1994
69. 69. Wagner RD, Pierson C, Warner T, Dohnalek M, Farmer J, Roberts L, Hilty M, Balish E: Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 65:4165-4172, 1997
70. 70. Crohn BB, Ginzburg L, Oppenheimer GD: Regional enteritis: A pathologic and clinical entity. J Am Med Assoc 99:1323-1329, 1932
71. 71. Tomkins AM, Bradley AK, Oswald S, Drasar BS: Diet and the faecal microflora of infants, children and adults in rural Nigeria and urban UK. J Hyg 86:285-293, 1981
72. 72. Koletzko S, Sheman P, Corey M, Griffiths A, Smith C: Role of infant feeding practices in development of Crohn's disease in childhood. Br Med J 298:1617-1618, 1989
73. 73. Wiedemann W, Ketterle A, Naujoks R: Dental studies on the protective effect of breast feeding. Dtsche Zahnaerztl Z 34:427-429, 1979
74. 74. Beerens H, Romond C, Neut C: Influence of breast-feeding on the bifid flora of the newborn intestine. Am J Clin Nutr 33:2434-2439, 1980
75. 75. Martini G, Brandes J: Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Woschenshr 54:367-371, 1976
76. 76. Persson P-G, Tysk C, Anderson K, Jarnerot G: Smoking and inflammatory bowel disease. A control study. Gut 29:352-357, 1988
77. 77. Forrest E, Graham E, Russell R: Crohn's Arthropathy and NSAIDS: Associations and therapeutic difficulties. Gastroenterology 114:A978, 1998
78. 78. Evans J, McMahon A, Murray F, McDevitt D, MacDonald T: Nonsteroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 40:619-622, 1997
79. 79. MacFarlane GD, Herzberg MC, Wolff LF, Hardie NA: Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking. J Periodontol 63(11):908-913, 1992
80. 80. Geneo RJ: Current view of risk factors for periodontal diseases. J Periodontol 67(10 suppl):1041-1049, 1996
81. 81. Pabst MJ, Pabst KM, Collier JA, Coleman TC, Lemons-Prince ML, Godat MS, Waring MB, Babu JP: Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 66(12):1047-1055, 1995
82. 82. Sasagawa S, Suzuki K, Sakatani T, Fujikura T: Effects of nicotine on the functions of human polymorphonuclear leukocytes in vitro. J Leukoc Biol 37(5):493-502, 1985
83. 83. Sasagawa S, Kameda H, Sudo J, Tanabe T: Inhibitory effect of nicotine on chemiluminescence response of human polymorphonuclear leukocytes stimulated by opsonized zymosan in vitro. J Toxicol Sci 9(1):1-9, 1984
84. 84. Smith J, Walker J: The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemotaxis. Br J Pharmacol 69:473-478, 1080
85. 85. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S: Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42(4):470-476, 1998
86. 86. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT: Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34(12):1705-1709, 1993
87. 87. Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, Luzi C: An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91(2):328-332, 1996
88. 88. Bernstein L, Frank M, Brandt L: Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79:357-365, 1980
89. 89. Burnham W, Lennard-Jones J, Hecketsweiler P, Colin R, Geffroy Y: Oval BCG vaccine in Crohn's disease. Gut 20:229-233, 1979
90. 90. Sachar D, Rubin K. Gumaste V: Levamisole in Crohn's disease: A randomized, double-blind, controlled trial. Am J Gastroenterol 82:536-539, 1987
91. 91. Wesdorp E, Schellekens PT, Weening RS, Meuwissen SG, Tytgat GN: Levamisole in Crohn's disease - a double-blind controlled trial. Digestion 18(3-4):186-191, 1978
92. 92. Gionchetti P, Rizzello F, Venturi A, et al: Maintenance treatment of chronic pouchitis: A randomized, controlled trial with a new probiotic preparation. Gastroenterology 114:A985, 1998
93. 93. Ament ME, Ochs HD: Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med 288(8):382-387, 1973
94. 94. Yogman MW, Touloukian RJ, Gallagher R: Intestinal granulomatosis in chronic granulomatous disease and in Crohn's disease. N Engl J Med 290(4):228, 1974
95. 95. Harris BH, Boles ET Jr: Intestinal lesions in chronic granulomatous disease of childhood. J Pediatr Surg 8(6):955-956, 1973
96. 96. Wendel U, Bremer HJ, Willberg B: Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr 110(1):166, 1987
97. 97. Miyasaki KT: The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol 62:761-774, 1991